![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/821986/821986_Thumb_400.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer | Scientific Reports The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-24187-5/MediaObjects/41598_2022_24187_Fig1_HTML.png)
The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer | Scientific Reports
![CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4997-y/MediaObjects/12885_2018_4997_Fig1_HTML.png)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
![Frontiers | Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer Frontiers | Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer](https://www.frontiersin.org/files/Articles/741309/fonc-11-741309-HTML/image_m/fonc-11-741309-g001.jpg)
Frontiers | Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer
![Long-term survival of patients with stage III colon cancer treated with VRP- CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio | Journal for ImmunoTherapy of Cancer Long-term survival of patients with stage III colon cancer treated with VRP- CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001662/F1.large.jpg)
Long-term survival of patients with stage III colon cancer treated with VRP- CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio | Journal for ImmunoTherapy of Cancer
![Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer - Prager - 2014 - Cancer Science - Wiley Online Library Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer - Prager - 2014 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/99d8bd92-9313-432f-9ae3-4e79d2236d7c/cas12451-fig-0001-m.jpg)
Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer - Prager - 2014 - Cancer Science - Wiley Online Library
![High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer | World Journal of Surgical Oncology | Full Text High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-023-03056-z/MediaObjects/12957_2023_3056_Fig2_HTML.png)
High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer | World Journal of Surgical Oncology | Full Text
![Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-018-0115-9/MediaObjects/41416_2018_115_Fig3_HTML.png)
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer
Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status | PLOS ONE
![Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings](https://img.medscapestatic.com/pi/meds/ckb/69/38369tn.jpg)
Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings
![Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India | JCO Global Oncology Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India | JCO Global Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/go/2021/go.2021.7/go.21.00111/20210701/images/large/go.21.00111t3.jpeg)
Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India | JCO Global Oncology
![JCM | Free Full-Text | Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer JCM | Free Full-Text | Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer](https://www.mdpi.com/jcm/jcm-09-03848/article_deploy/html/images/jcm-09-03848-g001.png)
JCM | Free Full-Text | Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer
![The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/4/5/e004385/F6.large.jpg)
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open
![Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort | Annals of Surgical Oncology Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort | Annals of Surgical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-019-08148-3/MediaObjects/10434_2019_8148_Fig1_HTML.png)
Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort | Annals of Surgical Oncology
![Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/36/3/1041/F1.large.jpg)
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
![Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer | SpringerLink Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00423-021-02236-3/MediaObjects/423_2021_2236_Fig4_HTML.png)
Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer | SpringerLink
![Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine](https://www.thelancet.com/cms/asset/92fa2a4c-e9e8-42b6-be07-cb3711d901e7/gr1.jpg)